- The report contains detailed information about Cyberonics Inc. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
- Another part of the report is a SWOT-analysis carried out for Cyberonics Inc.. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
- The Cyberonics Inc. financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
- In the part that describes Cyberonics Inc. competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
- Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Cyberonics Inc. business.
About Cyberonics Inc.
Cyberonics, Inc., a neuromodulation company, engages in the design, development, sales, and marketing of implantable medical devices that provide vagus nerve stimulation therapy (VNS Therapy), for the treatment of refractory epilepsy and treatment-resistant depression.
The company's VNS Therapy System is indicated as an adjunctive treatment for patients who are refractory to antiepileptic drugs. Its VNS Therapy System is also indicated as an adjunctive treatment for patients 18 years of age or older who are experiencing a major depressive episode and have not had an adequate response to four or more adequate antidepressant treatments. In Canada and the European Union, VNS Therapy is indicated for the treatment of chronic or recurrent depression in patients who are in a treatment-resistant or treatment-intolerant major depressive episode.
VNS Therapy System
The companys VNS Therapy System is a proprietary, integrated system consisting of an implantable generator that delivers an electrical signal to an implanted lead attached to the left vagus nerve. The VNS Therapy System consists of a pulse generator, a bipolar lead, a programming wand and software, and a tunneling tool. The VNS Therapy System delivers stimulation by means of electrical pulses on a chronic, intermittent basis. The initial stimulation parameters that the company recommends are a 30-second period of stimulation, which is referred to as ON time, followed by a 5-minute period without stimulation, which is referred to as OFF time.
Pulse Generator: The pulse generator is an implantable, programmable signal generator designed to be coupled with the bipolar lead to deliver electrical pulses to the vagus nerve. The pulse generator is a battery powered device. The company offers the model 102, 102R, Demipulse, and Demipulse Duo VNS Therapy pulse generators in the U.S.
Bipolar Lead: The bipolar lead conveys the electrical signal from the pulse generator to the vagus nerve. The company offers three lead models in the U.S., which are available in two sizes of inner spiral diameter to optimal electrode placement on different size nerves.
Programming Wand and Software: The companys programming wand and proprietary software are used to interrogate the implanted pulse generator and to transmit programming information from a handheld computer to the pulse generator via electromagnetic signals. Programming capabilities include modification of the pulse generators programmable parameters (pulse width, amplitude, frequency and ON and OFF intervals) and storage and retrieval of telemetry data.
Tunneling Tool: The tunneling tool is a single use, sterile, disposable surgical tool designed to be used during surgical placement of the bipolar lead. The tool is used for subcutaneous tunneling of the lead assembly between the nerve site in the neck and the pulse generator site in the chest.
Accessory Pack: The accessory pack includes two resistor assemblies used to test the function of the device prior to implantation, the bipolar lead tie-downs and one hex screwdriver.
Patient Essentials Kit: The patient kit includes two magnets, one watch style, and one pager style.
The company markets and sells its products for refractory epilepsy through direct sales and marketing forces in the United States. It is approved to market its products in approximately 70 countries through a combination of a direct sales force in certain European countries and independent distributors elsewhere. The VNS Therapy System sold by a direct sales force in Austria, Belgium, Denmark, France, Germany, Ireland, Luxemburg, the Netherlands, Norway, Spain, Sweden, Switzerland, and the United Kingdom.
The company has distribution agreements with independent distributors covering various other territories, including Canada, Mexico, Australia, parts of Central and South America, China, Japan, and other parts of Asia, the Middle East, and the remaining areas of Europe.
Cyberonics, Inc. was founded in 1987.
The above Company Fundamental Report is a half-ready report and contents are subject to change.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get all the most recent data available for the same price. Please note that preparation of additional types of analyses requires extra time.
1. CYBERONICS INC. COMPANY PROFILE
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History
2. CYBERONICS INC. BUSINESS OVERVIEW
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units
3. CYBERONICS INC. SWOT ANALYSIS
4. CYBERONICS INC. FINANCIAL ANALYSIS
4.1.1. Income Statement
4.1.2. Balance Sheet
4.1.3. Cash Flow
4.2. Financial Ratios
4.2.2. Margin Analysis
4.2.3. Asset Turnover
4.2.4. Credit Ratios
4.2.5. Long-Term Solvency
4.2.6. Growth Over Prior Year
4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot
5. CYBERONICS INC. COMPETITORS AND INDUSTRY ANALYSIS
5.1. Cyberonics Inc. Direct Competitors
5.2. Comparison of Cyberonics Inc. and Direct Competitors Financial Ratios
5.3. Comparison of Cyberonics Inc. and Direct Competitors Stock Charts
5.4. Cyberonics Inc. Industry Analysis
5.4.1. Healthcare Equipment/Supplies Industry Snapshot
5.4.2. Cyberonics Inc. Industry Position Analysis
6. CYBERONICS INC. NEWS & EVENTS
6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events
7. CYBERONICS INC. EXPERTS REVIEW1
7.1. Experts Opinion
7.2. Experts Estimates
8. CYBERONICS INC. ENHANCED SWOT ANALYSIS2
9. UNITED STATES PESTEL ANALYSIS2
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors
10. CYBERONICS INC. IFE, EFE, IE MATRICES2
10.2. External Factor Evaluation Matrix
10.3. Internal External Matrix
11. CYBERONICS INC. PORTER FIVE FORCES ANALYSIS2
12. CYBERONICS INC. VRIO ANALYSIS2
APPENDIX: RATIO DEFINITIONS
LIST OF TABLES
Cyberonics Inc. Key Facts
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Cyberonics Inc. Key Executives
Key Executives Biographies1
Key Executives Compensations1
Cyberonics Inc. Major Shareholders
Cyberonics Inc. History
Cyberonics Inc. Products
Revenues by Segment
Revenues by Region
Cyberonics Inc. Offices and Representations
Cyberonics Inc. SWOT Analysis
Yearly Income Statement Including Trends
Income Statement Latest 4 Quarters Including Trends
Yearly Balance Sheet Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Yearly Cash Flow Including Trends
Cash Flow Latest 4 Quarters Including Trends
Cyberonics Inc. Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Cyberonics Inc. Capital Market Snapshot
Cyberonics Inc. Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Healthcare Equipment/Supplies Industry Statistics
Cyberonics Inc. Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Cyberonics Inc. Consensus Recommendations1
Analyst Recommendation Summary1
Price Target Summary1
Experts Recommendation Trends1
Revenue Estimates Analysis1
Earnings Estimates Analysis1
Revenue Estimates Trend1
Earnings Estimates Trend1
LIST OF FIGURES
Cyberonics Inc. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Cyberonics Inc. 1-year Stock Charts
Cyberonics Inc. 5-year Stock Charts
Cyberonics Inc. vs. Main Indexes 1-year Stock Chart
Cyberonics Inc. vs. Direct Competitors 1-year Stock Charts
Cyberonics Inc. Article Density Chart
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for publicly traded companies.
Enhanced SWOT Analysis
- How to use the strengths to take advantage of the opportunities?
- How to use the strengths to reduce likelihood and impact of the threats?
- How to overcome the weaknesses that obstruct taking advantage of the opportunities?
- How to overcome the weaknesses that can make the threats a reality?
Key Factors Examined by PESTEL Analysis:
- Legal – What laws and legislation will exert influence on the style the business is carried out?
IFE, EFE, IE Matrices
Porter Five Forces Analysis
- What composes a threat of substitute products and services?
- Is there a threat of new competitors entering the market?
- What is the intensity of competitive rivalry?
- How big is the bargaining power of buyers?
- How significant is the bargaining power of suppliers?
- Tangible resources
- Intangible resources
- Innovation and Creativity
- Organizational capabilities
- Costly to imitate?
- Organized properly?